BioMarin Pharmaceutical Inc. (BMRN) Outlook Lowered By Leerink

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is among the cheap healthcare stocks to buy heading into 2026. As reported by TheFly, Leerink reduced the price target on BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) to $60 from $82 and downgraded it to Market Perform from Outperform on December 3. According to the analyst, the actions taken by new leadership, including workforce cuts and discontinuing the Roctavian program, strengthen its long-term position. However, rising competitive pressure in achondroplasia ...